Molecular Staging

New Haven, CT August 13, 2001-- Molecular Staging Inc., today announced that, together with Amersham Pharmacia Bio-tech, the two companies have developed a simple method of using Rolling Circle Amplification to copy circular DNA for sequencing, 10,000...

New Haven, CT. June 4, 2001 - Molecular Staging Inc. (MSI) today confirmed that Motorola will not exercise an option to license Rolling Circle Amplification technology (RCAT™) for applications in the clinical diagnostics market. Instead, Motorola Inc....

Funding will enhance Molecular Staging’s leadership position in signal and target amplification and accelerate MSI’s efforts in the proteomics, genomics and molecular diagnostics markets. NEW HAVEN, CT -- Molecular Staging Inc. (MSI), a...

Ultra-sensitive Prototype Assay for Prostate Cancer Marker Also Reported PRINCETON, N.J., Oct. 2 /PRNewswire/ -- AxCell Biosciences Corporation, a subsidiary of Cytogen Corporation (Nasdaq: CYTO - news) and Molecular Staging, Inc., (MSI), Guilford, CT,...

PRINCETON, N.J., Sept. 28 /PRNewswire/ -- Cytogen Corporation (Nasdaq: CYTO) announced today that it had signed a letter of intent to obtain an exclusive, worldwide license from Molecular Staging, Inc. (MSI) of Guilford, CT, for their novel Rolling Circle...